{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:52:49Z","timestamp":1793134369637,"version":"4.5.0"},"reference-count":68,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,10,11]],"date-time":"2015-10-11T00:00:00Z","timestamp":1444521600000},"content-version":"vor","delay-in-days":283,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Mediators of Inflammation"],"published-print":{"date-parts":[[2015,1]]},"abstract":"<jats:p>\n                    Myeloproliferative neoplasms (essential thrombocythemia, ET; polycythemia vera, PV; myelofibrosis, MF) are monoclonal malignancies associated with genomic instability, dysregulated signaling pathways, and subsequent overproduction of inflammatory markers. Acknowledged for their debilitating symptom profiles, recent investigations have aimed to determine the identity of these markers, the upstream sources stimulating their development, their prevalence within the MPN population, and the role they play in symptom development. Creation of dedicated Patient Reported Outcome (PRO) tools, in combination with expanded access to cytokine analysis technology, has resulted in a surge of investigations evaluating the potential associations between symptoms and inflammation. Emerging data demonstrates clear relationships between individual MPN symptoms (fatigue, abdominal complaints, microvascular symptoms, and constitutional symptoms) and cytokines, particularly IL\u20101, IL\u20106, IL\u20108, and TNF\u2010\n                    <jats:italic>\u03b1<\/jats:italic>\n                    . Information is also compiling on the role symptoms paradoxically play in the development of cytokines, as in the case of fatigue\u2010driven sedentary lifestyles. In this paper, we explore the symptoms inherent to the MPN disorders and the potential role inflammation plays in their development.\n                  <\/jats:p>","DOI":"10.1155\/2015\/284706","type":"journal-article","created":{"date-parts":[[2015,10,12]],"date-time":"2015-10-12T19:14:08Z","timestamp":1444677248000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":109,"title":["Impact of Inflammation on Myeloproliferative Neoplasm Symptom Development"],"prefix":"10.1155","volume":"2015","author":[{"given":"Holly L.","family":"Geyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amylou C.","family":"Dueck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn M.","family":"Scherber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben A.","family":"Mesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,10,11]]},"reference":[{"key":"e_1_2_8_1_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-170449"},{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2010.32.2446"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-328955"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.3183.3183"},{"key":"e_1_2_8_5_2","article-title":"Insomnia, quality of life and MPN symptom burden: an analysis by the MPN quality of life international study group (MPN-QOL ISG)","volume":"122","author":"Geyer H.","year":"2013","journal-title":"Blood"},{"key":"e_1_2_8_6_2","article-title":"Sexuality challenges, intimacy, and MPN symptom burden: an analysis by the MPN quality of life international study group (MPN-QOL ISG)","volume":"122","author":"Geyer H.","year":"2013","journal-title":"Blood"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-09-527903"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22365"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2009.01.035"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26129"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V118.21.2814.2814"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1110557"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.096669"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.3863"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.03.023"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s000180050394"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-11-394775"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200737772"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.11.015"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-348755"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2012.10.020"},{"key":"e_1_2_8_22_2","first-page":"39","article-title":"Idiopathic myelofibrosis. Clinical aspects and studies on extracellular matrix metabolism","volume":"40","author":"Hasselbalch H. C.","year":"1993","journal-title":"Danish Medical Bulletin"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2010.32.9490"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.4074.4074"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23295"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2014.01.006"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.3220.3220"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.031070"},{"key":"e_1_2_8_29_2","first-page":"337","article-title":"Bone marrow histochemical studies of fibrogenic cytokines and their receptors in myelodysplastic syndrome with myelofibrosis and related disorders","volume":"72","author":"Yoon S.-Y.","year":"2000","journal-title":"International Journal of Hematology"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050595"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2008.071030"},{"key":"e_1_2_8_32_2","article-title":"The molecular and cytokine profile of triple-negative (JAK2 V617F, JAK2 exon 12, MPL negative) myelofibrosis, a myeloproliferative neoplasm with distinct clinico-pathologic characteristics","volume":"633","author":"Tabarroki A.","year":"2012","journal-title":"Blood"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgh027"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2011.36.1154"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010915)92:6 <1684::AID-CNCR1497>3.0.CO;2-Z"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21234"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2006.08.001"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21671"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.8.1252"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.3173.3173"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.1862.1862"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci31772"},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-348144"},{"key":"e_1_2_8_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2014.12.017"},{"key":"e_1_2_8_45_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.psych.51.1.29"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000265062.92340.a5"},{"key":"e_1_2_8_47_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.13-08-03574.1993"},{"key":"e_1_2_8_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(91)90040-i"},{"key":"e_1_2_8_49_2","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.3376-06.2006"},{"key":"e_1_2_8_50_2","article-title":"The relationship between cytokine levels and symptoms in patients (Pts) with myelofibrosis (MF) from COMFORT-II, a phase 3 study of ruxolitinib (RUX) vs best available therapy (BAT)","volume":"122","author":"Harrison C. N.","year":"2013","journal-title":"Blood"},{"key":"e_1_2_8_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2005.04.010"},{"key":"e_1_2_8_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2004.01.009"},{"key":"e_1_2_8_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2006.07.006"},{"key":"e_1_2_8_54_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301946"},{"key":"e_1_2_8_55_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.007047"},{"key":"e_1_2_8_56_2","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.85"},{"key":"e_1_2_8_57_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1987.tb05787.x"},{"key":"e_1_2_8_58_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.3.575"},{"key":"e_1_2_8_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(96)00352-x"},{"key":"e_1_2_8_60_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199709051774"},{"key":"e_1_2_8_61_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mco.0000134363.53782.cb"},{"key":"e_1_2_8_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2005.03.014"},{"key":"e_1_2_8_63_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/89.23.1763"},{"key":"e_1_2_8_64_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.2001.280.5.R1518"},{"key":"e_1_2_8_65_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2507"},{"key":"e_1_2_8_66_2","doi-asserted-by":"publisher","DOI":"10.1249\/01.jes.0000240027.22749.14"},{"key":"e_1_2_8_67_2","article-title":"Changes in activated bone marrow macrophages and mast cells in patients with myelofibrosis following ruxolitinib therapy","volume":"124","author":"Kvasnicka H. M.","year":"2014","journal-title":"Blood"},{"key":"e_1_2_8_68_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.1874.1874"}],"container-title":["Mediators of Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/mi\/2015\/284706.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/mi\/2015\/284706.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/2015\/284706","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T17:37:13Z","timestamp":1722879433000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/2015\/284706"}},"subtitle":[],"editor":[{"given":"Sylvie","family":"Hermouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["10.1155\/2015\/284706"],"URL":"https:\/\/doi.org\/10.1155\/2015\/284706","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725915771.793516229","asserted-by":"object"}]},"ISSN":["0962-9351","1466-1861"],"issn-type":[{"value":"0962-9351","type":"print"},{"value":"1466-1861","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"2015-06-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-08-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-10-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"284706"}}